You did everything right. You talked to your doctor, you started an antidepressant, you gave it time, and maybe you tried a second one. Yet the depression is still there. If this sounds familiar, you are not alone, and you are not out of options. When major depression has not improved adequately after multiple appropriate treatment trials, clinicians may describe it as treatment-resistant depression. It affects a significant number of people who live with depression.
The most important thing to know is that “resistant” does not mean “hopeless.” There are additional options, from adjusting your medication and therapy approach to treatments like TMS, esketamine, carefully supervised ketamine, and electroconvulsive therapy. At Ray of Hope in Columbus, our outpatient programs, including our Intensive Outpatient Program, help people who feel stuck find a path forward.
What Is Treatment-Resistant Depression?
Treatment-resistant depression, sometimes shortened to TRD, generally refers to major depression that has not responded adequately to at least two different antidepressant medications, each taken consistently at an appropriate dose for a sufficient period. There is no single universally accepted definition, but failure to improve after two adequate antidepressant trials is the most common standard.
It is more common than many people assume. Not improving after the first antidepressant is common. In the STAR*D study, about one-third of participants reached remission with the first medication, while many others needed additional treatment steps. Estimates suggest that up to about one-third of people with depression may eventually meet commonly used definitions of treatment-resistant depression.
Living with TRD can be discouraging, especially after getting your hopes up more than once. But a lack of response to the first treatments does not mean nothing will work. It usually means the standard path was not the right fit for you and that a more tailored approach is needed. If you are still trying to understand your symptoms, our guide on the 10 signs of depression you shouldn’t ignore is a helpful starting point.
Why Antidepressants Sometimes Don’t Work
Before concluding that depression is truly treatment resistant, it is worth understanding why medications sometimes fall short. Often, the issue is not that no treatment can help, but that something has been getting in the way. Common reasons include:
- An incomplete or incorrect diagnosis. Conditions like bipolar disorder can look like depression but require different treatment. Our overview of bipolar I, II, and cyclothymia explains why this distinction matters.
- Dose, duration, or adherence issues. A medication may not have been taken consistently, at a high enough dose, or for long enough to evaluate its full effect.
- Co-occurring conditions. Untreated anxiety, trauma, sleep problems, or substance use can complicate symptoms and affect how well a treatment plan works, as explored in our article on the interplay of depression and substance abuse.
- Medical factors. Thyroid disorders, sleep conditions, medication effects, substance use, and selected nutritional problems can cause or worsen depression-like symptoms.
- Genetic differences. Genetic differences may affect how the body metabolizes certain medications, influencing drug levels, side effects, or dosing. However, they do not reliably predict which antidepressant will work.
Sorting through these possibilities with a professional is an essential part of figuring out what to try next.
What to Try Next: Treatment Options for TRD
If antidepressants have not worked, there is a growing range of depression treatment options to explore. The right choice depends on your diagnosis, treatment history, symptoms, safety needs, previous side effects, and preferences. It is best decided alongside a knowledgeable provider.
Adjusting or Combining Medication
Sometimes the answer lies in refining the medication approach rather than abandoning it. This might mean switching to a different class of antidepressant, adjusting the dose, or adding a second medication to boost the first, a strategy known as augmentation.
A careful review of the diagnosis, previous medication trials, adherence, side effects, and treatment response is often the first step when antidepressants don’t work.
TMS (Transcranial Magnetic Stimulation)
TMS for depression is a non-invasive, FDA-cleared treatment that uses magnetic pulses to stimulate targeted areas of the brain involved in mood regulation. It is performed in an outpatient setting and does not require anesthesia.
Treatment usually involves repeated sessions over several weeks, although the schedule and session length vary by device and protocol. Most people can return to their normal activities afterward, although headaches, scalp discomfort, lightheadedness, or fatigue may occur.
TMS can provide meaningful symptom improvement for some people whose depression has not responded to medication, although it does not work for everyone.
You can learn more in our deep dive on transcranial magnetic stimulation.
Ketamine and Esketamine
Ketamine for depression has emerged as a promising option, particularly because some people experience improvement within hours or days rather than weeks. However, the effect is not universal and may not last without additional treatment.
Intravenous ketamine is sometimes used off-label for treatment-resistant depression. This means it is not FDA-approved specifically for depression, although some clinics provide it under medical supervision.
Esketamine is a nasal spray derived from ketamine that is FDA-approved for adults with treatment-resistant depression. It may be used alone or with an oral antidepressant and must be administered under direct medical supervision in a certified healthcare setting.
Ketamine and esketamine work differently from traditional antidepressants, but they also carry risks. These may include sedation, dissociation, dizziness, increased blood pressure, impaired coordination, respiratory problems, and concerns about misuse. Careful screening, monitoring, and follow-up are essential.
Electroconvulsive Therapy (ECT)
Electroconvulsive therapy is one of the most established and effective treatments for severe or highly treatment-resistant depression. It is performed under anesthesia and uses a carefully controlled electrical current to produce a brief therapeutic seizure.
ECT may be recommended when depression involves psychosis, catatonia, severe suicidal risk, an inability to eat or care for basic needs, or a need for rapid improvement. It may also be considered after several other treatments have failed.
ECT can cause temporary confusion and memory problems, and the risks and benefits should be reviewed carefully with a specialist. Despite common misconceptions, it remains an important evidence-based option for appropriately selected patients.
Intensive Outpatient Programs (IOP)
For many people, the missing piece is not a single new medication but a more comprehensive, structured level of support. An Intensive Outpatient Program provides several hours of therapy per week, combining individual counseling, group support, psychiatric care, progress monitoring, and skill-building while still allowing you to live at home and maintain your routine.
This added structure may help when weekly therapy is not providing enough support. An IOP can support a broader treatment-resistant depression plan, but it is a level of care rather than a direct substitute for treatments such as TMS, esketamine, ketamine, or ECT when those are clinically indicated.
Therapy and Other Approaches
Evidence-based therapies remain a cornerstone of care, even for stubborn depression. Cognitive behavioral therapy, explored in our article on who can benefit from CBT, helps reshape the thought patterns that fuel depression. Group therapy adds connection and shared understanding, as discussed in our comparison of group therapy versus individual therapy.
Group therapy adds connection and shared understanding, as discussed in our comparison of group therapy versus individual therapy. Depending on the person, treatment may also include behavioral activation, interpersonal therapy, sleep treatment, trauma-focused care, family support, or lifestyle changes that support recovery.
Comparing Advanced Treatment Options
Each of these approaches works differently and suits different situations. The table below offers a quick side-by-side look to help frame a conversation with your provider.
| Treatment | How It Works | Setting | Often Considered For |
|---|---|---|---|
| Medication adjustment | Switching, optimizing, combining, or augmenting medications | Outpatient or structured program | A common next step after limited or partial response |
| TMS | Magnetic stimulation of targeted brain areas | Specialized outpatient setting | Depression that has not improved after adequate treatment trials |
| Ketamine | Off-label treatment that acts through glutamate-related brain systems | Medically supervised clinic | Selected people with TRD who understand the benefits, limits, and risks |
| Esketamine | FDA-approved nasal medication for adult TRD | Certified, medically supervised setting | TRD after inadequate response to previous antidepressant treatment |
| ECT | Produces a controlled therapeutic seizure under anesthesia | Hospital or specialized medical setting | Severe, psychotic, suicidal, catatonic, or highly resistant depression |
| Intensive Outpatient Program | Coordinates frequent therapy, psychiatric support, monitoring, and skill-building | Outpatient | People needing more structure than weekly treatment without 24-hour hospitalization |
This comparison is a general guide, not medical advice. A qualified professional can help determine which option, or combination of options, fits your needs.
Finding the Right Path Forward
Perhaps the most important message about treatment-resistant depression is this: not responding to the first or second treatment does not mean recovery is impossible. Many people benefit from later treatment steps, although finding an effective and tolerable approach may require careful reassessment and specialist care.
The key is continuing to work with professionals who take your experience seriously and are willing to review the diagnosis, treatment history, risks, and full range of options.
At Ray of Hope in Columbus, our outpatient services include individual therapy, group therapy, psychiatric support, and structured programming through our Intensive Outpatient Program. Our team helps people who have struggled with depression that will not lift by addressing factors that may have blocked progress and coordinating treatment planning. When specialized treatments are appropriate, referrals or collaboration with other providers may be part of the plan.
You do not have to keep facing this alone.
If you are thinking about suicide or harming yourself, call or text 988 or use the 988 online chat. If you are in immediate danger, cannot stay safe, or need urgent medical attention, call 911.
Treatment-Resistant Depression: Frequently Asked Questions
What qualifies as treatment-resistant depression?
Treatment-resistant depression generally refers to major depression that has not improved adequately after at least two appropriate antidepressant trials. Each trial should involve a sufficient dose, duration, and adherence. Because definitions vary, a clinician should also review the diagnosis, previous response, side effects, co-occurring conditions, and other possible reasons treatment has not worked.
Does TMS or ketamine work when antidepressants don’t?
TMS, off-label ketamine, and FDA-approved esketamine can help some people whose depression has not improved with antidepressants, but none of these treatments works for everyone.
TMS uses magnetic pulses to stimulate targeted brain regions. Ketamine and esketamine act through different brain systems and may work more rapidly for some people. Each option has different risks, monitoring requirements, costs, and treatment schedules.
Can an outpatient program help with stubborn depression?
Yes. An Intensive Outpatient Program can provide more structure than weekly therapy through frequent individual and group sessions, psychiatric support, medication monitoring, progress tracking, and coping-skills practice.
An IOP may be appropriate for people who can remain safe while living at home, but it does not guarantee a response and is not a substitute for inpatient care or specialized treatments when those are needed.
